Medulloblastoma metastatic to the pancreas: a case report  by Gavini, Hemanth et al.
lable at ScienceDirect
Gastrointest Interv 2014; 3:116–119Contents lists avaiGastrointestinal Intervention
journal homepage: www.gi - intervent ion.orgCase ReportMedulloblastoma metastatic to the pancreas: a case report
Hemanth Gavini,1 Venkat D. Arukala,1 John Stewart,2 Jeffrey H. Lee1,*a b s t r a c t
We present a case of medulloblastoma metastatic to the pancreas in a 41-year-old woman with recurrent cerebellar medulloblastoma. On presentation,
computed tomography of the abdomen and pelvis showed a 2.2 cm  2.6 cm hypodense pancreatic head mass associated with obstruction of the
pancreatic duct. Endosonography with ﬁne needle aspiration (EUS-FNA) was performed. Cytology showed a malignant small cell neoplasm that was
consistent with medulloblastoma and was morphologically identical to the primary cerebellar medulloblastoma. Metastatic medulloblastoma to the
pancreas is an extremely rare form of a secondary pancreatic tumor and very few case reports exist in the literature. The diagnosis rests on comparing
cytological features when primary and secondary tumors are both available.
Copyright  2014, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved.
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pancreatic duct dilation (arrow).Introduction
Medulloblastoma may account for up to 20% of central nervous
system (CNS) tumors in the pediatric population, which makes it
the most common CNS malignancy in children.1 However, this
entity comprises only 0.4–1% of CNS neoplasms in adults.2 It is
usually restricted to the CNS, and metastases often occur along the
neuroaxis.3 Systemic (i.e., extraneural) metastasis is rare but por-
tends a poor prognosis. Metastasis to the pancreas is relatively
uncommon, and usually diagnosed at autopsy in association with
extensive metastasis to other organ systems.4,5 We report a case of
metastatic medulloblastoma involving the pancreas that was
diagnosed by endosonography with ﬁne needle aspiration (EUS-
FNA) in a woman with recurrent medulloblastoma.
Case Report
In 2009, a 41-year old African-American woman was admitted
to our hospital with worsening severe occipital headaches and neck
and back pain associated with difﬁculty in maintaining balance.
Magnetic resonance imaging (MRI) of the head, showed a contrast
enhancing mass in the posterior fossa. The patient underwent
bilateral suboccipital craniotomy with total resection of the tumor,
but had no ventriculoperitoneal shunt placed. The pathology of the
tumor was consistent with medulloblastoma. She postoperatively
developed syndrome of inappropriate antidiuretic hormone
secretion (SIADH). She continued to have difﬁculty in maintaining
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cisplatin and etoposide for three cycles, followed by eight cycles of
cyclophosphamide and vincristine. However, 1 week into her ra-
diation therapy, she developed severe intractable nausea, vomiting,
mucositis associated with odynophagia, and dysphagia. She
therefore lost 30 pounds. Because of her poor performance status,rson Cancer Center, Houston, TX, USA
USA
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Fig. 2. The endosonography scan shows a heterogeneous mass in the head of the
pancreas.
Fig. 3. Endosonography with ﬁne needle aspiration of the pancreatic mass in pancreas.
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(CSF) analysis obtained by lumbar puncture did not reveal any
malignant cells.
One month later, a repeat MRI scan to evaluate worsening
dysarthria and ataxia showed progression of the disease. She wasFig. 4. Fine needle aspiration cytology (left) with Diff-Quik stain at 500 magniﬁcation an
cohesive malignant small cell neoplasmwith neuroendocrine features (i.e., ﬁne chromatin an
Diff-Quik stain. Mitotic ﬁgures and apoptotic bodies are present.subsequently started on chemotherapy with cisplatin, etoposide,
cyclophosphamide and carboplatin. A repeat MRI revealed pro-
gression of the disease with a signiﬁcant increase in the size of the
tumor. She then underwent a redo midline posterior fossa crani-
otomy for excision of the tumor; its pathology was consistent with
recurrent medulloblastoma. This was complicated by a CSF leak
from her incision, which required a repeat posterior fossa crani-
otomy to indirectly repair the CSF leak and to place a lumbar spinal
drain. This was followed by intensity modulated radiation therapy
to 40 Gy in 20 fractions.
Approximately 8 months later, she presented to the emergency
center complaining of midepigastric pain with nausea and vomit-
ing. Computerized tomography (CT) of the abdomen and pelvis
showed a 2.2 cm  2.6 cm hypodense mass in the head of the
pancreas and dilation of the pancreatic duct (Fig. 1). She underwent
EUS-FNA on the 2.3-cm heterogeneous mass, which contained
multiple small anechoic spaces mixed with hyperechoic and
hypoechoic areas in the head of the pancreas. The mass abutted the
portal vein. Multiple hyperechoic strands with a lobular appear-
ance were in the body and tail of pancreas (Figs. 2, 3). Cytological
smears and cell block sections with immunoperoxidase stains
showed a malignant small cell neoplasm that represented an un-
usual high grade primary pancreatic neuroendocrine carcinoma or
a metastatic medulloblastoma (Figs. 4, 5). The absence of keratin
expression and the close morphologic similarity between the
pancreatic aspirate and the histologic sections of the patient’s
recurrent medulloblastoma favored metastatic medulloblastoma
over a second primary high grade pancreatic neuroendocrine
neoplasm. A positron emission tomography/CT scan showed mul-
tiple osseous metastases and metastatic disease to the proximal
pancreas. Informed consent was obtained from the patient for this
report.Discussion
This is the ﬁrst case of medulloblastoma with pancreatic
metastasis diagnosed antemortem by EUS-FNA in the English
literature. After glioblastoma and meningioma, medulloblastoma is
the third most common CNS tumor to exhibit systemic metastases.
In 1955, Weiss6 proposed rigid criteria for diagnosing extracraniald (right) with Papanicolaou stain at 600 magniﬁcation. The smears show a loosely
d inconspicuous nucleoli). The cells have scant cytoplasm that is best visualized on the
Fig. 5. Fine needle aspiration with cell block (400 magniﬁcation). H&E staining shows malignant small cell neoplasm with necrosis. Immunoperoxidase stains are positive for the
neuroendocrine markers chromogranin (diffuse), synaptophysin (focal), and CD56 (focal); and is negative for the keratins AE1/AE3 and CAM5.2. H&E, hematoxylin and eosin.
Table 1 Summary of Clinical Data of Previously Reported Patients with Me-
dulloblastoma Metastatic to the Pancreas
Study Sex/age Tumor
type
Recurrence/
residual
disease in CNS
Extraneural
metastasis
Paterson 195314 M/2 DM þ Bone marrow
Lymph nodes
Pelvis
Parotids
Liver
Pancreas
Rubinstein and
Northﬁeld 196415
M/13 CM _ Bone marrow
Bones
Thymus
Lymph nodes
Testis
Pancreas
Lewis et al 197313 M/43 DM þ Bone marrow
Bones
Lymph nodes
Liver lung Pancreas
Ureters
Kleinman et al 19815 F/26 DM þ Bone marrow
Bones
Lymph nodes
Pleura
Retrosternal muscles
Sphenoid sinus
Adrenal cortex
Liver
Pancreas
Krouwer et al 19914 F/46 DM _ Pancreas
CM, cerebellar medulloblastoma; DM, desmoplastic medulloblastoma; F, female; M,
male.
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single histologically characteristic CNS tumor, a clinical history
indicating a primary CNS lesion, a complete postmortem exami-
nation to exclude peripheral primary tumor, and similar histolog-
ical ﬁndings between the CNS and peripheral lesions.6 In this
patient, all of these criteria were fulﬁlled antemortem.
After the initial diagnosis of medulloblastoma, the average in-
terval to the development of extraneural metastasis is 18 months.
In some patients, 13 years have elapsed after the initial diagnosis
before metastasis developed.7 Our patient, who had a high risk for
metastasis, survived 3 years prior to being diagnosed. Osseous
metastases (77%) are the most frequent site for extracranial spread
in adults, followed by lymph nodes (33%) lungs (17%), muscle (13%),
liver (10%), and the pleura.
The spread of a primary CNS neoplasm extracranially occurs
primarily by seeding via CSF pathway8 (which gives rise to subdural
subarachnoid metastasis9,10) and within the central canal of the
spinal cord5 via a hematogenous route or lymphatic route. Reports
have also described spread by shunt tubing as a consequence of
tumor cells escaping into the systemic circulation owing to the
break in the blood–brain barrier. This potentially occurs as a result
of tumor surgery with the insertion of a cerebrospinal shunt.11,12
Metastasis to the bone and pancreas in our patient made hema-
togeneous spread more likely.
To our knowledge there are only ﬁve reported cases4,5,13–15 in
which medulloblastoma metastasized to the pancreas (Table 1). In
four of these cases, the diagnosis was made at autopsy with
metastasis to other systems. In one case report, the diagnosis was
made antemortem by percutaneous needle biopsy.4 In our patient
Hemanth Gavini et al. / Medulloblastoma metastatic to the pancreas 119with recurrent medulloblastoma, the diagnosis was made ante-
mortem by EUS–FNA of the mass in the pancreas, which allowed
detailed evaluation of the pancreas and acquisition of tissue diag-
nosis in one setting.
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